DSE : NAVANAPHAR

Navana Pharmaceuticals PLC — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 59.3 BDT (At close: Oct 29, 2026) · Market cap 6.37B

Latest research: Navana Pharmaceuticals financial analysis: 28% sales growth, BDT 750m interest bill and falling debt (Oct 2026) · Navana Pharmaceuticals: sales up 28% and factories at 98% of capacity, but interest takes half of operating profit

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap6.37B
Enterprise Value10.02B

Dates

MeasureValue
Earnings DateNov 4, 2026
Ex-Dividend DateNov 25, 2026

Shares

MeasureValue
Current Share Class107.42M
Shares Outstanding107.42M
Shares Change (YoY)+0.74%
Shares Change (QoQ)+0.29%
Owned by Insiders (%)23.53%
Owned by Institutions (%)n/a
Float39.44M

Ratios

MeasureValue
PE Ratio10.58
Forward PEn/a
PS Ratio0.60
PB Ratio1.20
P/TBV Ratio1.20
P/FCF Ratio3.36
P/OCF Ratio2.68
PEG Ration/a

Evratios

MeasureValue
EV / Earnings16.53
EV / Sales0.95
EV / EBITDA5.62
EV / EBIT6.71
EV / FCF5.29

Financialposition

MeasureValue
Current Ratio0.91
Quick Ratio0.31
Debt / Equity0.74
Debt / EBITDA2.20
Debt / FCF2.07
Interest Coverage2.44

Financialefficiency

MeasureValue
Return on Equity (ROE)11.90%
Return on Assets (ROA)8.17%
Return on Invested Capital (ROIC)12.31%
Return on Capital Employed (ROCE)25.45%
Weighted Average Cost of Capital (WACC)7.72%
Revenue Per Employee2.20M
Profits Per Employee126,329
Employee Count4,798
Asset Turnover0.93
Inventory Turnover2.54

Taxes

MeasureValue
Income Tax204.43M
Effective Tax Rate25.22%

Stockprice

MeasureValue
Beta (5Y)0.23
52-Week Price Change+15.15%
50-Day Moving Average63.57
200-Day Moving Average62.94
Relative Strength Index (RSI)37.28
Average Volume (20 Days)209,584

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue10.57B
Gross Profit4.58B
Operating Income1.49B
Pretax Income810.56M
Net Income606.13M
EBITDA1.73B
EBIT1.49B
Earnings Per Share (EPS)5.60

Balancesheet

MeasureValue
Cash & Cash Equivalents229.54M
Total Debt3.92B
Net Cash-3.65B
Net Cash Per Share-33.96
Equity (Book Value)5.32B
Book Value Per Share49.53
Working Capital-515.87M

Cashflow

MeasureValue
Operating Cash Flow2.38B
Capital Expenditures-481.66M
Depreciation & Amortization236.65M
Net Borrowing-1.10B
Free Cash Flow1.89B
FCF Per Share17.63

Margins

MeasureValue
Gross Margin43.29%
Operating Margin14.12%
Pretax Margin7.67%
Profit Margin5.74%
EBITDA Margin16.36%
EBIT Margin14.12%
FCF Margin17.92%

Dividends

MeasureValue
Dividend Per Share1.40
Dividend Yield2.36%
Dividend Growth (YoY)-57.14%
Years of Dividend Growthn/a
Payout Ratio8.47%
FCF Payout Ratio3.40%
Buyback Yield-0.74%
Shareholder Yield1.62%
Earnings Yield9.45%
FCF Yield29.73%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score2.07
Piotroski F-Score7

Fairvalue

MeasureValue
Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside